You are hereHome ›
Frontiers operates under and advisory structure that ensures input and buy-in from within and from its partners and the community.
The Frontiers Leadership Team is comprised of leadership from Frontiers institutions and components who meet monthly to provide input on key adminsitrative issues.
External Advisory Board (EAB)
The EAB meets annually to provide guideance and advice based on their own experience in leadership roles at other Clinical and Translational Science Award (CTSA) sites around the country. Members include
- Gary Rosenthal, MD, Director of the Institute for Clinical and Translational Research at the University of Iowa
- Julian Solway, MD, Director of the University of Chicago Institute for Translational Medicine
- Bradley Evanoff, MD, MPH, Director of the Institute for Clinical and Translational Sciences at Washington University in St. Louis
- Daniel Masys, MD, Affiliate Professor of Biomedical and Health Informatics at the University of Washington.
Frontiers has three distinct regional Councils which enable the Frontiers and its leadership to be responsive to the needs of these constituents and to benefit from their input:
The Frontiers leadership will seriously consider all suggestions and concerns raised by the Councils and the External Scientific Advisory Committee. The input of these groups, however, is advisory and not binding. The director, in consultation with the deputy director, must be able to make all final decisions that affect the Frontiers as a whole. If a Council or the External Scientific Advisory Committee makes a recommendation that is not accepted, the Frontiers director will provide that group a rationale and explanation.